Juni 2024
Phospholipid Research Center, Heidelberg
PD Dr. Simon Drescher, Managing Director at Phospholipid Research Center, Heidelberg, invites you cordially to participate in the 8th International Symposium on Phospholipids in Pharmaceutical Research from Monday to Wednesday on September 9 –11, 2024, in Heidelberg (Germany)
See the programme here:
www.phospholipid-research-center.com/event/
Registration
To register for the symposium, please use the attached Registration Form.
Abstract Submission
Let us kindly know whether you want to contribute with a poster or short presentation. Please visit the website for instructions. The deadline for registration and abstract submission is July 15, 2024.
Questions
Please get in touch for any questions at the Phospholipid Research Center under symposium@phospholipid-research-center.com
Accelerating the RNA-Revolution in Medicine
CAN BE VIEWED NOW AS ONLINE REVIEW
Due to the huge interest for its contents, we have asked the speakers to allow us to bring the speeches online. Watch the presentations of the outstanding experts in RNA. This is an offer for 8 weeks. Click here: Debate 1 – Online Review
Sponsors:
See latest Issue: PRNANO
A Nonprofit Gold Open Access https://precisionnanomedicine.com/
INVITATION TO READ AND TO WRITE IN THE PRNANO CLINAM JOURNAL
This journal does not charge submission or APC (article procession) fees.
Without charge
All content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author.
The Mission
The journal promotes all practical, rational, and progressive aspects of nanomedicine including theory and practice. Authors are invited to send submissions in basic science, translational, preclinical, and clinical research.
PRNANO accepts original manuscripts, as well as replication studies and discussions of negative results as long as they are clearly marked as such and move the field forward.
Support
We support authors who wish to share their work early through deposition of manuscripts with preprint servers such as bioRxiv or arXiv, have previously been presented at conferences, published as a thesis or have previously appeared in other “non-journal” venues (for example: blogs or posters).
Aim and scope
The journal exists to provide a good quality and supportive publishing forum with quick turnaround time for nanomedicine researchers and provides a cutting-edge and reliable source of information to societies, for libraries, and to the interested public without additional cost.
Online only
PRNANO is online only. Articles are published continuously on a rolling basis, then organized into quarterly issues (January, April, July, and October) and annual volumes. All articles receive a unique identifier (DOI:10.33218 / prnano) and are archived both in Portico and Crossref, for preservation. We are members of COPE and our green archiving policy is registered in Sherpa/Romeo, i.e., pre-print and post-print PDFs, as well as publisher’s versions can be archived, without restrictions.
NOTE: We are signatories of the San Francisco Declaration on Research Assessment. We advise against the use of journal-based metrics, such as Journal Impact Factors, as a surrogate measure of the quality of individual research articles, to assess an individual scientist’s contributions, or in hiring, promotion, or funding decisions. We support article-based metrics and follow the publication policies of WHO.
